Lv1
24 积分 2025-05-31 加入
Le protéasome, la seconde vie d’une cible thérapeutique validée : aspects structuraux et nouveaux inhibiteurs
6天前
已完结
New trends in synthetic drugs and natural products targeting 20S proteasomes in cancers
6天前
已完结
Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells
9天前
已完结
Proteome-wide mapping of cholesterol-interacting proteins in mammalian cells
15天前
已完结
Comprehensive analysis of kinase inhibitor selectivity
2个月前
已完结
How were new medicines discovered?
2个月前
已完结
Cinobufagin overcomes bortezomib resistance in multiple myeloma strains by targeting SEC62/TRPM4-mediated NECSO
2个月前
已完结
Cinobufagin overcomes bortezomib resistance in multiple myeloma strains by targeting SEC62/TRPM4-mediated NECSO
2个月前
已完结
Recent advances in analytical separation techniques for therapeutic oligonucleotides
3个月前
已完结
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
3个月前
已完结
皖公网安备34019202002308
